Patent · US Active

Anti-CD40 antibodies

US10577425B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

ALLIGATOR BIOSCIENCE AB · SE

Inventors

Peter Ellmark · Lund, SE
Karin Enell Smith · Lund, SE
Niina Veitonmaki · Lund, SE

Key dates

Filing date	Dec 18, 2014
Grant date	Mar 3, 2020
Priority date	—
Expiry date	Feb 26, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides an antibody or fragment thereof that specifically binds to human CD40.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.